The industry's fastest clinical trials monitoring and risk platform.
Get real-time updates on new trials, drug risks, and competitor programs. Our AI is always on so you don’t have to be.
Trusted by the World’s Most Innovative Biotech Companies
Automation
Instantly sift out irrelevant and obsolete data
Save your team hours with AI that automatically finds important signals and removes unnecessary and out-of-date clinical trials information.
Contextual Insights
Know when something happens — and why it happened
Unlike ambiguous email alerts that offer little explanation, you always get the full context behind any change.
Early Risk Detection
Catch red flags months in advance
Be the first to know about any setbacks so you can adjust your trial or investment plan and save your team millions of dollars.
From Lab to Market, AI is Reshaping Biotech
Drug approvals have increased by 60% over the last decade. But with great innovation comes great information—so much information in fact, that it has become impossible to sort through it all manually.
Through our partnership with STAT News we developed a rigorous, expert-approved AI that keeps you informed and agile by detecting signals that are impossible to uncover otherwise.
In partnership with
Biotech Language Model
Generate reports with striking precision and speed
A real-time generative model that turns raw, unorganized data into digestible insights that adhere to rigorous standards of journalism.
Join the most innovative biotech companies and speed up your clinical intelligence
Solutions
Save 5+ hours a week with robust clinical intelligence without the data overload
Competitive Intelligence
Keep track of competitor trials, timelines, and roadblocks and create go-to-market plans that are agile, informed, and set up to succeed.
Learn more
Competitive Intelligence
Keep track of competitor trials, timelines, and roadblocks and create go-to-market plans that are agile, informed, and set up to succeed.
Learn more
Customer Stories
Leading biotech teams use AI to stay on top of market conditions, drugs, competitors, and regulatory changes
Could Irregular Clinical Trial Activity Have Predicted Zuranolone’s MDD Rejection?
Read case study
AI’s Impact on Drug Design, Regenerative Medicine, and Beyond with Stem Cell Expert Dr. Ermelinda Porpiglia
Read case study
Introducing AppliedXL’s AI Brand: Elevating Speed & Transparency in Computational Journalism Through Design
Read case study
Using AI to Improve Decision-Making in Biotech: Insights from MindMed’s Chief Medical Officer
Read case study